Texas HB4673 modifies how reductions in out-of-pocket expenses for certain prescription drugs affect cost-sharing requirements for health benefit.

Texas HB4673 amends the Insurance Code to specify how reductions in out-of-pocket expenses for prescription drugs, particularly those without generic equivalents or biological products, should be applied to an enrollee's cost-sharing requirements. These reductions apply to the enrollee's deductible, copayment, cost-sharing responsibility, or out-of-pocket maximum. The changes apply to health benefit plans delivered, issued for delivery, or renewed on or after January 1, 2026.

Texas HB4673 modifies how reductions in out-of-pocket expenses for certain prescription drugs affect cost-sharing requirements for health benefit.

Texas HB4673 amends the Insurance Code to specify how reductions in out-of-pocket expenses for prescription drugs, particularly those without generic equivalents or biological products, should be applied to an enrollee's cost-sharing requirements. These reductions apply to the enrollee's deductible, copayment, cost-sharing responsibility, or out-of-pocket maximum. The changes apply to health benefit plans delivered, issued for delivery, or renewed on or after January 1, 2026.